Your browser doesn't support javascript.
loading
Lung function fluctuation patterns unveil asthma and COPD phenotypes unrelated to type 2 inflammation.
Delgado-Eckert, Edgar; James, Anna; Meier-Girard, Delphine; Kupczyk, Maciej; Andersson, Lars I; Bossios, Apostolos; Mikus, Maria; Ono, Junya; Izuhara, Kenji; Middelveld, Roelinde; Dahlén, Barbro; Gaga, Mina; Siafakas, Nikos M; Papi, Alberto; Beghe, Bianca; Joos, Guy; Rabe, Klaus F; Sterk, Peter J; Bel, Elisabeth H; Johnston, Sebastian L; Chanez, Pascal; Gjomarkaj, Mark; Howarth, Peter H; Nizankowska-Mogilnicka, Ewa; Dahlén, Sven-Erik; Frey, Urs.
Affiliation
  • Delgado-Eckert E; University of Basel, University Children's Hospital, Basel, Switzerland.
  • James A; Center for Allergy Research, Karolinska Institutet, Stockholm, Sweden.
  • Meier-Girard D; University of Basel, University Children's Hospital, Basel, Switzerland.
  • Kupczyk M; Center for Allergy Research, Karolinska Institutet, Stockholm, Sweden; Department of Internal Medicine, Asthma and Allergy, Medical University of Lodz, Lodz, Poland.
  • Andersson LI; Center for Allergy Research, Karolinska Institutet, Stockholm, Sweden.
  • Bossios A; Center for Allergy Research, Karolinska Institutet, Stockholm, Sweden; Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Huddinge and Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Mikus M; Center for Allergy Research, Karolinska Institutet, Stockholm, Sweden.
  • Ono J; Shino-Test Corporation Ltd, Sagamihara, Japan.
  • Izuhara K; Division of Medical Biochemistry, Department of Biomolecular Sciences, Saga Medical School, Saga, Japan.
  • Middelveld R; Center for Allergy Research, Karolinska Institutet, Stockholm, Sweden.
  • Dahlén B; Center for Allergy Research, Karolinska Institutet, Stockholm, Sweden; Department of Respiratory Medicine and Allergy, Karolinska University Hospital, Huddinge and Department of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
  • Gaga M; University of Athens, Athens, Greece.
  • Siafakas NM; University of Crete, Crete, Greece.
  • Papi A; University of Ferrara, Ferrara, Italy.
  • Beghe B; University of Modena and Reggio Emilia, Italy.
  • Joos G; University of Ghent, Ghent, Belgium.
  • Rabe KF; Christian Albrechts University Kiel, Kiel, Germany.
  • Sterk PJ; Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Bel EH; Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Johnston SL; The Imperial College of Science and Technology, London, United Kingdom.
  • Chanez P; University of Marseilles, Marseilles, France.
  • Gjomarkaj M; Italian Research Council, Palermo, Italy.
  • Howarth PH; University of Southampton, Southampton, United Kingdom.
  • Nizankowska-Mogilnicka E; The Jagellonian University, Krakow, Poland.
  • Dahlén SE; Center for Allergy Research, Karolinska Institutet, Stockholm, Sweden. Electronic address: Sven-Erik.Dahlen@ki.se.
  • Frey U; University of Basel, University Children's Hospital, Basel, Switzerland.
J Allergy Clin Immunol ; 148(2): 407-419, 2021 08.
Article de En | MEDLINE | ID: mdl-33548398
ABSTRACT

BACKGROUND:

In all chronic airway diseases, the dynamics of airway function are influenced by underlying airway inflammation and bronchial hyperresponsiveness along with limitations in reversibility owing to airway and lung remodeling as well as mucous plugging. The relative contribution of each component translates into specific clinical patterns of symptoms, quality of life, exacerbation risk, and treatment success.

OBJECTIVE:

We aimed to evaluate whether subgrouping of patients with obstructive airway diseases according to patterns of fluctuation in lung function allows identification of specific phenotypes with distinct clinical characteristics.

METHODS:

We applied the novel method of fluctuation-based clustering (FBC) to twice-daily FEV1 measurements recorded over a 1-year period in a mixed group of 134 adults with mild-to-moderate asthma, severe asthma, or chronic obstructive pulmonary disease from the European BIOAIR cohort.

RESULTS:

Independently of clinical diagnosis, FBC divided patients into 4 fluctuation-based clusters with progressively increasing alterations in lung function that corresponded to patterns of increasing clinical severity, risk of exacerbation, and lower quality of life. Clusters of patients with airway disease with significantly elevated levels of biomarkers relating to remodeling (osteonectin) and cellular senescence (plasminogen activator inhibitor-1), accompanied by a loss of airway reversibility, pulmonary hyperinflation, and loss of diffusion capacity, were identified. The 4 clusters generated were stable over time and revealed no differences in levels of markers of type 2 inflammation (blood eosinophils and periostin).

CONCLUSION:

FBC-based phenotyping provides another level of information that is complementary to clinical diagnosis and unrelated to eosinophilic inflammation, which could identify patients who may benefit from specific treatment strategies or closer monitoring.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tests de la fonction respiratoire / Asthme / Broncho-pneumopathie chronique obstructive / Remodelage des voies aériennes Type d'étude: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: J Allergy Clin Immunol Année: 2021 Type de document: Article Pays d'affiliation: Suisse

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tests de la fonction respiratoire / Asthme / Broncho-pneumopathie chronique obstructive / Remodelage des voies aériennes Type d'étude: Clinical_trials / Prognostic_studies Aspects: Patient_preference Limites: Adult / Aged / Female / Humans / Male / Middle aged Langue: En Journal: J Allergy Clin Immunol Année: 2021 Type de document: Article Pays d'affiliation: Suisse
...